全体要約
市場は、先進的な創傷処置製品、従来の創傷処置製品、手術用創傷処置製品にセグメント化されています。2022年には、先進的な創傷処置製品が最も高い成長率を記録しました。また、創傷タイプ別では慢性創傷が最も高い成長率を示しました。地域別では、アジア太平洋地域が最も高いCAGRを達成する見込みです。
関連する質問
21.5 billion USD (2023)
5.9% (2023-2028)
3M Company, Smith & Nephew PLC, Cardinal Health, Medtronic PLC, B. Braun Melsungen AG, Baxter International, Inc., Mölnlycke Health Care AB, Convatec Group, Paul Hartmann AG, Coloplast A/S, Organogenesis Holdings Inc., MiMedx Group, Inc., Integra Life Sciences Holdings Corporation, Bioventus, Zimmer Biomet Holdings, Inc., Ethicon, Inc., DeRoyal Industries, Kerecis, Acell, Lohmann & Rauscher GmbH & Co. KG, Medela Ag, Talley Group, Welcare Industries SPA, Wuhan VSD Medical Science & Technology Co. Ltd., Pensar Medical, Haromed BVBA, DermaRite Industries LLC, Medline Industries, Inc., Advancis Medical LLC, Mil Laboratories Pvt. Ltd.
外傷および外科的創傷の発生率の上昇, 先進的な創傷処置製品の技術革新, 高齢人口の増加による慢性疾患の有病率の上昇
概要
「先進的な創傷ケア製品セグメントは、予測期間中に製品別で創傷ケア市場において最も高い成長率を占めました。」
創傷ケア市場は、高度な創傷ケア製品、伝統的な創傷ケア製品、外科的創傷ケア製品にセグメント化されています。2022年には、高度な創傷ケア製品セグメントが創傷ケア市場で最も高い成長率を記録しました。この成長は、外傷および外科的創傷の発生率が大幅に増加したことに主に起因しており、このセグメント内で高度な創傷ケアソリューションの需要を大きく押し上げています。
慢性創傷セグメントは、予測期間中に創傷ケア市場で創傷タイプ別に最も高い成長率を占めました。
創傷ケア市場は、創傷の種類に基づいて慢性創傷と急性創傷にセグメント化されます。2022年には、慢性創傷セグメントが創傷ケア市場で最も高い成長率を記録しました。この成長は主に高齢化人口に起因しており、世界的な高齢化の進行に伴い、糖尿病、末梢動脈疾患、静脈疾患などの慢性疾患の有病率が高くなり、これらすべてが慢性創傷を引き起こす可能性があります。また、さまざまな地域での医療費の増加や医療インフラの改善が専門的な創傷ケア製品へのより良いアクセスを可能にし、慢性創傷ケア市場の成長を促進しています。
「在宅ケア設定セグメントは、最高のCAGRを占めました。」
エンドユーザーに基づいて、創傷ケア市場は病院とクリニック、長期患者ケア、在宅ケア設定、その他のエンドユーザーにセグメント化されています。2022年には、在宅ケア設定セグメントが最も高いCAGRを占めました。技術、遠隔医療、専門の創傷ケア製品、熟練した医療専門家を在宅ケア設定に統合することで、在宅での創傷ケアの提供が進展しています。
「アジア太平洋：創傷ケア市場で最も成長が速い地域。」
創傷ケア市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカのセグメントに分かれており、アジア太平洋地域が予測期間中に最も重要なCAGRを達成することが予想されています。この成長は、外科的創傷を減少させることへの強調と、この地域内での外傷性創傷の効果的な管理への焦点の増加によって推進されています。
この報告書のために実施された主要なインタビューは、次のように分類できます：
・会社の種類別：ティア1 - 40%、ティア2 - 30%、ティア3 - 30%
・地位別：Cレベル - 27%、Dレベル - 18%、その他 - 55%
地域別: 北米 - 51%、ヨーロッパ - 21%、アジア太平洋 - 18%、ラテンアメリカ - 6%、中東・アフリカ - 4%
レポートに掲載された企業のリスト：
• 3M社（アメリカ）
・スミス・アンド・ネフューPLC（英国）
・カーディナルヘルス（米国）
メドトロニック PLC（アイルランド）
B. ブラウン メルズンゲン AG（ドイツ）
• バクスターインターナショナル社（アメリカ）
・モーリンレッキ・ヘルスケア株式会社（スウェーデン）
コンバテックグループ（英国）
ポール・ハートマンAG（ドイツ）
・コロプラストA/S（デンマーク）
オルガノジェネシス・ホールディングス株式会社（アメリカ）
ミメデックス・グループ・インク（アメリカ）
インテグラライフサイエンスホールディングスコーポレーション（米国）
・バイオベンツス(アメリカ)
・ジマー・バイオメット・ホールディングス（アメリカ）
エチコン社（アメリカ）
・デロイヤル・インダストリーズ（米国）
• ケレキス (アイスランド)
・アセル（米国）
• Lohmann & Rauscher GmbH & Co. KG（ドイツ）
• メデラ社 (スイス)
タリーグループ (英国)
ウェルケア・インダストリーズ SPA（イタリア）
• 武漢VSD医療科学技術有限公司（中国）
・ペンサーメディカル（アメリカ）
ハロメッド BVBA（ベルギー）
デマライト産業 LLC (米国)
メドライン・インダストリーズ・インク（米国）
アドバンシス・メディカル・LLC（英国）
• ミルラボラトリーズ株式会社（インド）
調査内容：
この研究報告書は、創傷ケア市場を製品、創傷タイプ、エンドユーザーおよび地域によって分類しています。報告書の範囲は、創傷ケア市場の成長に影響を与える主要な要因（ドライバー、制約、課題、機会など）に関する詳細な情報を含んでいます。主要な業界プレイヤーに関する詳細な分析が行われており、彼らのビジネス概要、ソリューション、主要戦略、契約、パートナーシップ、合意、新製品の発売、合併と買収、創傷ケア市場に関連する最近の動向についての洞察が提供されています。創傷ケア市場エコシステムにおける新興スタートアップの競争分析も本報告書で取り上げられています。
レポート購入の主要な利点：
この報告書は、市場リーダーや新規参入者に対して、全体の創傷ケア市場およびそのサブセグメントの収益数値に最も近い推定値を提供することで役立ちます。また、ステークホルダーが競争環境をよりよく理解し、ビジネスを適切に位置づけ、適切な市場進出戦略を策定するための洞察を得るのにも役立ちます。この報告書は、ステークホルダーが市場の動向を理解し、主要な市場のドライバー、制約、課題、機会に関する情報を提供することを可能にします。
この報告書は、以下のポイントについての洞察を提供します。
• 傷のケア市場の成長に影響を与える主な要因の分析（傷の治癒能力に影響を与える疾患や状態の増加、傷のケア製品における技術革新）、制約（高度な傷のケア製品に関連する高コスト、高度な傷のケア製品の使用に伴うリスク）、機会（新興国での成長機会）、課題（規制当局による製品リコールの増加、認知度の不足）。
• 製品開発/イノベーション：創傷ケア市場における新しい技術、研究開発活動、及び新製品の発売に関する詳細なインサイト。
市場開発: 収益性の高い市場に関する包括的な情報 - 報告書は様々な地域における創傷ケア市場を分析しています。
• 市場の多様化：創傷ケア市場における新製品、未開拓地域、最近の開発、及び投資に関する詳細情報。
競争評価：3M社（米国）、スミス・アンド・ネフュー社（英国）、カーディナルヘルス社（米国）、およびメドトロニック社（アイルランド）などの、創傷ケア市場戦略における主要プレーヤーの市場ランキング、成長戦略、製品提供についての詳細な評価です。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 37
1.1 調査の目的 37
1.2 市場の定義 37
1.2.1 研究の対象および対象外 38
1.3 対象市場 38
1.3.1 市場セグメンテーション 38
1.3.2 対象地域 39
1.3.3 対象年 39
1.4 通貨 40
1.5 制約 40
1.6 ステークホルダー 40
1.7 変化のサマリー 41
1.8 リセッション時のインパクト 41
2 調査手法 42
2.1 リサーチデータ 42
2.2 調査アプローチ 42
2.2.1 二次データ 43
- 2.2.1.1 二次情報の主要データ 43
2.2.2 一次データ 44
- 2.2.2.1 一次情報 44
- 2.2.2.2 一次情報の主要データ 45
- 2.2.2.3 業界についての主な考察 46
- 2.2.2.4 一次インタビュー内訳 46
2.3 市場規模予測 47
2.3.1 ボトムアップアプローチ 48
- 2.3.1.1 アプローチ1：会社の収益推定アプローチ 48
- 2.3.1.2 アプローチ2：企業プレゼンテーションと一次インタビュー 48
- 2.3.1.3 成長予測 49
- 2.3.1.4 CAGR予測 49
2.3.2 トップダウンアプローチ 50
2.4 市場の内訳とデータのトライアンギュレーション 51
2.5 市場シェア 52
2.6 調査の前提 52
2.7 リスク評価 53
2.8 方法論とスコープに関する限界 53
2.9 成長率の前提 53
2.10 創傷処置市場への不況の影響 54
3 エグゼクティブサマリー 55
4 更なる考察 58
4.1 創傷処置市場の概要 58
4.2 創傷処置市場シェア、製品別 2023年 vs. 2028年 59
4.3 創傷処置市場シェア、創傷タイプ別、2023年対2028年 59
4.4 創傷処置市場シェア、エンドユーザー別 2023年 vs. 2028年 60
4.5 創傷処置市場、地理的側面での成長機会 60
5 市場概要 61
5.1 イントロダクション 61
5.2 市場力学 61
5.2.1 促進要因 62
5.2.2 抑制要因 67
- 5.2.2.1 先進創傷処置製品の高価格化 67
- 5.2.2.2 先進創傷ケア製品使用時のリスクについて 68
5.2.3 市場機会 68
- 5.2.3.1 新興国の成長ポテンシャル 68
5.2.4 課題 70
- 5.2.4.1 規制当局による製品回収の増加 70
- 5.2.4.2 意識の低さ 70
5.3 価格分析 70
5.4 特許分析 72
5.4.1 主要な特許リスト 73
5.5 バリューチェーン分析 74
5.6 サプライチェーン分析 75
5.7 エコシステム分析 76
5.7.1 創傷処置市場：エコシステムにおける役割 77
5.8 ポーターのファイブフォース分析 77
5.8.1 新規参入の脅威 78
5.8.2 代替品の脅威 78
5.8.3 買い手の交渉力 78
5.8.4 サプライヤーの交渉力 78
5.8.5 競合・競争状況の激しさ 78
5.9 規制の概観 78
5.9.1 北米 80
- 5.9.1.1 米国 80
- 5.9.1.2 カナダ 80
5.9.2 ヨーロッパ 81
5.9.3 アジア太平洋 81
- 5.9.3.1 中国 81
- 5.9.3.2 日本 81
- 5.9.3.3 インド 81
5.9.4 ラテンアメリカ 81
- 5.9.4.1 ブラジル 81
- 5.9.4.2 メキシコ 82
5.9.5 中東 82
5.9.6 アフリカ 82
5.10 PESTLE分析（外部環境） 83
5.11 取引分析・貿易分析 84
5.11.1 接着剤付きドレッシングの貿易分析 84
5.12 技術分析 85
5.13 2023-2024年の主なカンファレンス＆イベント 85
5.14 顧客ビジネスにインパクトを与えるトレンドやディスラプション 87
5.14.1 COVID-19パンデミックにより収益源がテクノロジーベースのソリューションにシフト 87
5.14.2 創傷処置市場の収益シフト 88
5.15 主なステークホルダーと購入基準 88
5.15.1 購買プロセスにおける主要ステークホルダー 88
5.15.2 購買基準 89
5.16 ケーススタディ分析 90
5.16.1 ケーススタディ手術創が3週間で好転 90
6 創傷処置の市場、製品別 91
6.1 イントロダクション 92
6.1.1 プライマリーノート 92
- 6.1.1.1 業界についての主な考察 92
6.2 先進創傷ケア製品 92
6.2.1 高度創傷被覆材、タイプ別 94
- 6.2.1.1 発泡ドレッシング 95
- 6.2.1.1.1 シリコーンドレッシング 97
- 6.2.1.1.2 非シリコーン系ドレッシング 98
- 6.2.1.2 ハイドロコロイド製ドレッシング 99
- 6.2.1.2.1 最適な治癒に必要な湿潤環境を促進 99
- 6.2.1.3 フィルムドレッシング 101
- 6.2.1.3.1 非吸収性であるため、強力な採用が可能 101
- 6.2.1.4 アルジネートドレッシング 102
- 6.2.1.4.1 糖尿病および足潰瘍に最適 102
- 6.2.1.5 ハイドロゲルドレッシング 103
- 6.2.1.5.1 効果的な使用のためにいくつかの形態で利用可能 103
- 6.2.1.6 コラーゲンドレッシング 104
- 6.2.1.6.1 創傷治癒を促進するサイトカインや成長因子の分泌を助ける 104
- 6.2.1.7 ハイドロファイバードレッシング 106
- 6.2.1.7.1 ハイドロコロイドとコラーゲンの特性を併せ持つ 106
- 6.2.1.8 巻線コンタクト層 107
- 6.2.1.8.1 創傷床を細菌や真菌の繁殖から守る 107
- 6.2.1.9 高吸水性ドレッシング 108
- 6.2.1.9.1 滲出性の高い創傷用に設計 108
- 6.2.1.10 その他の高度創傷被覆材 109
- 6.2.1.1 発泡ドレッシング 95
6.2.2 高度創傷被覆材、特性別 111
- 6.2.2.1 非抗菌性ドレッシング 111
- 6.2.2.1.1 代替抗菌剤よりも費用対効果が高い 111
- 6.2.2.2 抗菌ドレッシング 113
- 6.2.2.2.1 潜在的な病原体に対する包括的なカバレッジを提供 113
- 6.2.2.1 非抗菌性ドレッシング 111
6.2.3 創傷治療機器 113
- 6.2.3.1 携帯型および従来型の陰圧創傷治療器 115
- 6.2.3.2 デブリードマン装置および付属品 116
- 6.2.3.2.1 市場成長を支える新規技術開発 116
- 6.2.3.3 創傷評価・モニタリング機器 117
- 6.2.3.3.1 採用を後押しするコスト削減の可能性 117
- 6.2.3.4 その他の機器・アクセサリー 119
6.2.4 生物学的皮膚代替物 121
- 6.2.4.1 ヒトドナー組織由来製品 123
- 6.2.4.1.1 市場の需要を支える高い有効性 123
- 6.2.4.2 動物由来の無細胞製品 125
- 6.2.4.3 生合成製品 126
- 6.2.4.3.1 市場成長を支える感染創傷の増加 126
- 6.2.4.1 ヒトドナー組織由来製品 123
6.2.5 外用剤 127
- 6.2.5.1 在宅ケアの現場における費用対効果と使いやすさが成長の原動力に 127
6.3 外科用創傷処置製品 128
6.3.1 縫合糸 130
- 6.3.1.1 採用を後押しする高い引張強度 130
6.3.2 ティッシュペーパー用接着剤、シーラント、グルー 132
- 6.3.2.1 フィブリン系シーラント 133
- 6.3.2.1.1 縫合よりも良い結果をもたらす 133
- 6.3.2.2 シンセティック接着剤 135
- 6.3.2.2.1 従来のステープルよりも優れた密閉性 135
- 6.3.2.3 コラーゲン系シーラント 136
- 6.3.2.3.1 止血剤の補助として外科手術に使用 136
- 6.3.2.1 フィブリン系シーラント 133
6.3.3 ホッチキス 137
- 6.3.3.1 縫合より速く正確 137
6.4 従来の創傷処置用製品 138
6.4.1 医療用テープ 140
- 6.4.1.1 創傷の一次治療に使用し、創傷を覆って固定 140
6.4.2 ドレッシング 141
6.4.3 クレンジング剤 142
- 6.4.3.1 開放創からのHAIの高いリスクが市場を牽引 142
7 創傷処置の市場、傷タイプ別 144
7.1 イントロダクション 145
7.2 急性創傷 145
7.2.1 外科的・外傷性創傷 146
- 7.2.1.1 手術件数の増加が市場を牽引 146
7.2.2 バーンズ 148
- 7.2.2.1 火傷の多発が市場を牽引 148
7.3 慢性創傷 150
7.3.1 糖尿病性足潰瘍 151
- 7.3.1.1 糖尿病有病率の増加が市場成長を支える 151
7.3.2 褥瘡（じょくそう 154
- 7.3.2.1 老年人口の増加が市場成長を促進 154
7.3.3 静脈性下腿潰瘍 155
- 7.3.3.1 肥満の増加が市場を牽引 155
7.3.4 その他の慢性創傷 157
8 創傷処置の市場、エンドユーザー別 159
8.1 イントロダクション 160
8.2 病院・クリニック 160
8.2.1 入院向け設定 163
- 8.2.1.1 HAIによる入院患者の増加が市場を牽引 163
8.2.2 外来向け設定 164
8.3 ホームケア設定 165
8.3.1 市場成長を支える低コストと利便性 165
8.4 長期療養型施設 166
8.4.1 高齢者人口の増加により、より良い長期介護の需要が高まる 166
8.5 その他のエンドユーザー 167
9 創傷処置の市場、地域別 169
9.1 はじめに 170
9.2 北米 170
9.2.1 北米創傷処置市場への不況の影響 177
9.2.2 米国 177
- 9.2.2.1 慢性疾患と糖尿病の増加が市場を牽引 177
9.2.3 カナダ 178
- 9.2.3.1 HAIの高い蔓延が市場成長を支える 178
9.3 ヨーロッパ 180
9.3.1 欧州創傷処置市場への景気後退の影響 187
9.3.2 ドイツ 187
9.3.3 フランス 188
- 9.3.3.1 老年人口の増加が市場成長を促進 188
9.3.4 英国 189
- 9.3.4.1 慢性創傷の増加が市場成長を促進 189
9.3.5 イタリア 190
9.3.6 スペイン 192
- 9.3.6.1 交通事故件数の増加が市場を押し上げる 192
9.3.7 ロシア 193
- 9.3.7.1 糖尿病に対する認識を高める政府の取り組みが市場成長を後押し 193
9.3.8 その他ヨーロッパ 194
9.4 アジア太平洋 200
9.4.1 アジア太平洋創傷処置市場への不況の影響 206
9.4.2 中国 206
- 9.4.2.1 糖尿病性足潰瘍の増加が市場を牽引 206
9.4.3 日本 208
- 9.4.3.1 充実した医療制度の存在が市場成長を後押し 208
9.4.4 インド 209
- 9.4.4.1 医療ツーリズムの拡大が市場成長を支える 209
9.4.5 オーストラリア 210
9.4.6 韓国 211
- 9.4.6.1 老人人口の増加が市場成長を後押し 211
9.4.7 シンガポール 212
- 9.4.7.1 糖尿病有病率の増加が市場成長を支える 212
9.4.8 その他アジア太平洋 213
9.5 ラテンアメリカ 218
9.5.1 ラテンアメリカ創傷処置市場への景気後退の影響 224
9.5.2 ブラジル 224
- 9.5.2.1 ラテンアメリカ最大のヘルスケア市場 224
9.5.3 メキシコ 225
- 9.5.3.1 糖尿病の負担増が市場を牽引 225
9.5.4 その他ラテンアメリカ 226
9.6 中東・アフリカ 231
9.6.1 糖尿病有病率の上昇が市場成長を支える 231
9.6.2 中東・アフリカ創傷処置市場への不況の影響 236
10 競合情勢 237
10.1 概要 237
10.2 主要プレイヤーの戦略 237
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN WOUND CARE MARKET 238
10.3 市場トッププレイヤーの収益分析 240
10.4 市場シェア分析 241
10.4.1 創傷処置市場 241
10.4.2 先進創傷ケア市場 242
10.4.3 陰圧創傷治療（npwt）市場 243
10.4.4 高度創傷被覆材市場 243
10.4.5 外科用縫合糸市場 244
10.4.6 デブリードマン装置市場 244
10.4.7 伝統的・外科的創傷処置製品市場 245
10.5 企業評価マトリックス 245
10.5.1 評価したベンダーのリスト 245
10.5.2 STARS 245
10.5.3 EMERGING LEADERS 245
10.5.4 PERVASIVE PLAYERS 245
10.5.5 PARTICIPANTS 246
10.5.6 企業フットプリント 247
10.6 スタートアップ/中小企業評価マトリックス 248
10.6.1 PROGRESSIVE COMPANIES 248
10.6.2 RESPONSIVE COMPANIES 248
10.6.3 DYNAMIC COMPANIES 248
10.6.4 STARTING BLOCKS 248
10.6.5 競合ベンチマーキング 250
10.7 競合シナリオ 251
10.7.1 製品展開 251
10.7.2 ディール 252
11 企業プロファイル 253
11.1 主要企業 253
11.1.1 3M COMPANY 253
11.1.2 CARDINAL HEALTH 260
11.1.3 MEDTRONIC PLC 266
11.1.4 SMITH & NEPHEW PLC 271
11.1.5 MÖLNLYCKE HEALTH CARE AB 278
11.1.6 B. BRAUN MELSUNGEN AG 282
11.1.7 BAXTER INTERNATIONAL, INC 285
11.1.8 CONVATEC GROUP PLC 288
11.1.9 PAUL HARTMANN AG 292
11.1.10 COLOPLAST A/S 296
11.1.11 ORGANOGENESIS INC 299
11.1.12 MIMEDX GROUP, INC 302
11.1.13 INTEGRA LIFESCIENCES CORPORATION 305
11.1.14 BIOVENTUS LLC 309
11.1.15 ZIMMER BIOMET HOLDINGS, INC 312
11.2 他の有力企業 315
11.2.1 ETHICON, INC 315
11.2.2 DEROYAL INDUSTRIES, INC 316
11.2.3 KERECIS 318
11.2.4 ACELL INC 319
11.2.5 LOHMANN & RAUSCHER GMBH & CO. KG 320
11.2.6 MEDELA AG 322
11.2.7 TALLEY GROUP LTD 322
11.2.8 WELCARE INDUSTRIES S.P.A 323
11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD 323
11.2.10 PENSAR MEDICAL, LLC 324
11.2.11 HAROMED BV 325
11.2.12 DERMARITE INDUSTRIES, LLC 326
11.2.13 MEDLINE INDUSTRIES, INC 327
11.2.14 ADVANCIS MEDICAL LLC 330
11.2.15 MIL LABORATORIES PVT. LTD 331
12 付録 332
12.1 ディスカッションガイド 332
12.2 ナレッジストア 337
12.3 カスタマイズオプション 339
12.4 関連レポート 339
12.5 執筆者の詳細 340
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY 38
1.3 MARKETS COVERED 38
1.3.1 MARKET SEGMENTATION 38
1.3.2 REGIONAL SCOPE 39
1.3.3 YEARS CONSIDERED 39
1.4 CURRENCY 40
1.5 LIMITATIONS 40
1.6 STAKEHOLDERS 40
1.7 SUMMARY OF CHANGES 41
1.8 RECESSION IMPACT 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
2.2 RESEARCH APPROACH 42
2.2.1 SECONDARY DATA 43
- 2.2.1.1 Key data from secondary sources 43
2.2.2 PRIMARY DATA 44
- 2.2.2.1 Primary sources 44
- 2.2.2.2 Key data from primary sources 45
- 2.2.2.3 Key industry insights 46
- 2.2.2.4 Breakdown of primary interviews 46
2.3 MARKET SIZE ESTIMATION 47
2.3.1 BOTTOM-UP APPROACH 48
- 2.3.1.1 Approach 1: Company revenue estimation approach 48
- 2.3.1.2 Approach 2: Presentations of companies and primary interviews 48
- 2.3.1.3 Growth forecast 49
- 2.3.1.4 CAGR projections 49
2.3.2 TOP-DOWN APPROACH 50
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 51
2.5 MARKET SHARE 52
2.6 STUDY ASSUMPTIONS 52
2.7 RISK ASSESSMENT 53
2.8 METHODOLOGY & SCOPE-RELATED LIMITATIONS 53
2.9 GROWTH RATE ASSUMPTIONS 53
2.10 RECESSION IMPACT ON WOUND CARE MARKET 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 58
4.1 WOUND CARE MARKET OVERVIEW 58
4.2 WOUND CARE MARKET SHARE, BY PRODUCT, 2023 VS. 2028 59
4.3 WOUND CARE MARKET SHARE, BY WOUND TYPE, 2023 VS. 2028 59
4.4 WOUND CARE MARKET SHARE, BY END USER, 2023 VS. 2028 60
4.5 WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
5.2.1 DRIVERS 62
- 5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities 62
- 5.2.1.1.1 Growing geriatric population 62
- 5.2.1.1.2 Rising prevalence of diabetes 63
- 5.2.1.1.3 Increasing number of surgical procedures worldwide 64
- 5.2.1.2 Rising expenditure on chronic wounds 64
- 5.2.1.3 Increasing incidence of burn injuries 65
- 5.2.1.4 Rising cases of traumatic injuries 65
- 5.2.1.5 Technological advancements in wound care products 66
- 5.2.1.6 Rising use of regenerative medicine for wound management 67
- 5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities 62
5.2.2 RESTRAINTS 67
- 5.2.2.1 High cost of advanced wound care products 67
- 5.2.2.2 Risks associated with use of advanced wound care products 68
5.2.3 OPPORTUNITIES 68
- 5.2.3.1 Growth potential of emerging countries 68
5.2.4 CHALLENGES 70
- 5.2.4.1 Growing instances of product recalls by regulatory bodies 70
- 5.2.4.2 Dearth of awareness 70
5.3 PRICING ANALYSIS 70
5.4 PATENT ANALYSIS 72
5.4.1 LIST OF MAJOR PATENTS 73
5.5 VALUE CHAIN ANALYSIS 74
5.6 SUPPLY CHAIN ANALYSIS 75
5.7 ECOSYSTEM ANALYSIS 76
5.7.1 WOUND CARE MARKET: ROLE IN ECOSYSTEM 77
5.8 PORTER’S FIVE FORCES ANALYSIS 77
5.8.1 THREAT OF NEW ENTRANTS 78
5.8.2 THREAT OF SUBSTITUTES 78
5.8.3 BARGAINING POWER OF BUYERS 78
5.8.4 BARGAINING POWER OF SUPPLIERS 78
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.9 REGULATORY LANDSCAPE 78
5.9.1 NORTH AMERICA 80
- 5.9.1.1 US 80
- 5.9.1.2 Canada 80
5.9.2 EUROPE 81
5.9.3 ASIA PACIFIC 81
- 5.9.3.1 China 81
- 5.9.3.2 Japan 81
- 5.9.3.3 India 81
5.9.4 LATIN AMERICA 81
- 5.9.4.1 Brazil 81
- 5.9.4.2 Mexico 82
5.9.5 MIDDLE EAST 82
5.9.6 AFRICA 82
5.10 PESTEL ANALYSIS 83
5.11 TRADE ANALYSIS 84
5.11.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS 84
5.12 TECHNOLOGY ANALYSIS 85
5.13 KEY CONFERENCES & EVENTS IN 2023-2024 85
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 87
5.14.1 REVENUE SOURCES SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO COVID-19 PANDEMIC 87
5.14.2 REVENUE SHIFT IN WOUND CARE MARKET 88
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 88
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
5.15.2 BUYING CRITERIA 89
5.16 CASE STUDY ANALYSIS 90
5.16.1 CASE STUDY: SURGICAL WOUND TURNS AROUND IN 3 WEEKS 90
6 WOUND CARE MARKET, BY PRODUCT 91
6.1 INTRODUCTION 92
6.1.1 PRIMARY NOTES 92
- 6.1.1.1 Key industry insights 92
6.2 ADVANCED WOUND CARE PRODUCTS 92
6.2.1 ADVANCED WOUND DRESSINGS, BY TYPE 94
- 6.2.1.1 Foam dressings 95
- 6.2.1.1.1 Silicone dressings 97
- 6.2.1.1.1.1 Help expedite wound closure and reduce risk of maceration 97
- 6.2.1.1.2 Non-silicone dressings 98
- 6.2.1.1.2.1 Effective in scar removal and wound healing 98
- 6.2.1.1.1 Silicone dressings 97
- 6.2.1.2 Hydrocolloid dressings 99
- 6.2.1.2.1 Promotes moist environment required for optimal healing 99
- 6.2.1.3 Film dressings 101
- 6.2.1.3.1 Non-absorbable nature ensures strong adoption 101
- 6.2.1.4 Alginate dressings 102
- 6.2.1.4.1 Well-suited for diabetic & foot ulcers 102
- 6.2.1.5 Hydrogel dressings 103
- 6.2.1.5.1 Available in several forms for effective use 103
- 6.2.1.6 Collagen dressings 104
- 6.2.1.6.1 Help release cytokines and growth factors that expedite wound healing 104
- 6.2.1.7 Hydrofiber dressings 106
- 6.2.1.7.1 Combine properties of hydrocolloids and collagen 106
- 6.2.1.8 Wound contact layers 107
- 6.2.1.8.1 Protect wound beds from bacterial and fungal growth 107
- 6.2.1.9 Superabsorbent dressings 108
- 6.2.1.9.1 Designed for highly exuding wounds 108
- 6.2.1.10 Other advanced wound dressings 109
- 6.2.1.1 Foam dressings 95
6.2.2 ADVANCED WOUND DRESSINGS, BY PROPERTY 111
- 6.2.2.1 Non-antimicrobial dressings 111
- 6.2.2.1.1 More cost-effective than antimicrobial alternatives 111
- 6.2.2.2 Antimicrobial dressings 113
- 6.2.2.2.1 Provide comprehensive coverage against potential pathogens 113
- 6.2.2.1 Non-antimicrobial dressings 111
6.2.3 WOUND THERAPY DEVICES 113
- 6.2.3.1 Portable & conventional negative pressure wound therapy devices 115
- 6.2.3.1.1 Growing adoption of single-use NPWT devices in home care settings to drive market 115
- 6.2.3.2 Debridement devices & accessories 116
- 6.2.3.2.1 Development of novel technologies to support market growth 116
- 6.2.3.3 Wound assessment & monitoring devices 117
- 6.2.3.3.1 Potential cost-reducing capabilities to boost adoption 117
- 6.2.3.4 Other devices & accessories 119
- 6.2.3.1 Portable & conventional negative pressure wound therapy devices 115
6.2.4 BIOLOGICAL SKIN SUBSTITUTES 121
- 6.2.4.1 Human donor tissue-derived products 123
- 6.2.4.1.1 High efficacy to support market demand 123
- 6.2.4.2 Acellular animal-derived products 125
- 6.2.4.2.1 Increasing incidence of diabetic foot ulcers and burn injuries to drive market 125
- 6.2.4.3 Biosynthetic products 126
- 6.2.4.3.1 Increased incidence of infected wounds to support market growth 126
- 6.2.4.1 Human donor tissue-derived products 123
6.2.5 TOPICAL AGENTS 127
- 6.2.5.1 Cost-effectiveness and ease-of-use in home care settings to drive growth 127
6.3 SURGICAL WOUND CARE PRODUCTS 128
6.3.1 SUTURES 130
- 6.3.1.1 High tensile strength to drive adoption 130
6.3.2 TISSUE ADHESIVES, SEALANTS, AND GLUES 132
- 6.3.2.1 Fibrin-based sealants 133
- 6.3.2.1.1 Provide better results than sutures 133
- 6.3.2.2 Synthetic adhesives 135
- 6.3.2.2.1 Additional sealing properties than traditional staples 135
- 6.3.2.3 Collagen-based sealants 136
- 6.3.2.3.1 Used in surgical procedures as adjuncts to hemostatic agents 136
- 6.3.2.1 Fibrin-based sealants 133
6.3.3 STAPLERS 137
- 6.3.3.1 Faster and more accurate than suturing 137
6.4 TRADITIONAL WOUND CARE PRODUCTS 138
6.4.1 MEDICAL TAPES 140
- 6.4.1.1 Used for primary wound treatment to cover and secure wounds 140
6.4.2 DRESSINGS 141
- 6.4.2.1 Presence of large patient population for pressure ulcers to drive market 141
6.4.3 CLEANSING AGENTS 142
- 6.4.3.1 High risk of HAIs from open wounds to drive market 142
7 WOUND CARE MARKET, BY WOUND TYPE 144
7.1 INTRODUCTION 145
7.2 ACUTE WOUNDS 145
7.2.1 SURGICAL & TRAUMATIC WOUNDS 146
- 7.2.1.1 Rising volume of surgical procedures to drive market 146
7.2.2 BURNS 148
- 7.2.2.1 High incidence of burn injuries to drive market 148
7.3 CHRONIC WOUNDS 150
7.3.1 DIABETIC FOOT ULCERS 151
- 7.3.1.1 Increasing prevalence of diabetes to support market growth 151
7.3.2 PRESSURE ULCERS 154
- 7.3.2.1 Growing geriatric population to aid market growth 154
7.3.3 VENOUS LEG ULCERS 155
- 7.3.3.1 Rising prevalence of obesity to drive market 155
7.3.4 OTHER CHRONIC WOUNDS 157
8 WOUND CARE MARKET, BY END USER 159
8.1 INTRODUCTION 160
8.2 HOSPITALS & CLINICS 160
8.2.1 INPATIENT SETTINGS 163
- 8.2.1.1 Increasing hospital admissions due to HAIs to drive market 163
8.2.2 OUTPATIENT SETTINGS 164
- 8.2.2.1 Rising cost of inpatient facilities to increase demand for outpatient care settings 164
8.3 HOME CARE SETTINGS 165
8.3.1 LOW COST AND CONVENIENCE TO SUPPORT MARKET GROWTH 165
8.4 LONG-TERM CARE FACILITIES 166
8.4.1 GROWING GERIATRIC POPULATION TO INCREASE DEMAND FOR BETTER LONG-TERM CARE 166
8.5 OTHER END USERS 167
9 WOUND CARE MARKET, BY REGION 169
9.1 INTRODUCTIONS 170
9.2 NORTH AMERICA 170
9.2.1 RECESSION IMPACT ON NORTH AMERICAN WOUND CARE MARKET 177
9.2.2 US 177
- 9.2.2.1 Rising incidence of chronic diseases and diabetes to drive market 177
9.2.3 CANADA 178
- 9.2.3.1 High prevalence of HAIs to support market growth 178
9.3 EUROPE 180
9.3.1 RECESSION IMPACT ON EUROPEAN WOUND CARE MARKET 187
9.3.2 GERMANY 187
- 9.3.2.1 Large diabetic population to support wound care product development and commercialization 187
9.3.3 FRANCE 188
- 9.3.3.1 Rising geriatric population to drive market growth 188
9.3.4 UK 189
- 9.3.4.1 Rising incidence of chronic wounds to propel market growth 189
9.3.5 ITALY 190
- 9.3.5.1 Improving quality and accessibility to medical care to support market growth 190
9.3.6 SPAIN 192
- 9.3.6.1 Increasing number of road traffic accidents to propel market 192
9.3.7 RUSSIA 193
- 9.3.7.1 Government focus on increasing diabetes awareness to favor market growth 193
9.3.8 REST OF EUROPE 194
9.4 ASIA PACIFIC 200
9.4.1 RECESSION IMPACT ON ASIA PACIFIC WOUND CARE MARKET 206
9.4.2 CHINA 206
- 9.4.2.1 Increasing incidence of diabetic foot ulcers to drive market 206
9.4.3 JAPAN 208
- 9.4.3.1 Presence of well-developed healthcare system to favor market growth 208
9.4.4 INDIA 209
- 9.4.4.1 Growing medical tourism to support market growth 209
9.4.5 AUSTRALIA 210
- 9.4.5.1 Increasing initiatives to spread awareness of effective wound care to propel market 210
9.4.6 SOUTH KOREA 211
- 9.4.6.1 Rising geriatric population to aid market growth 211
9.4.7 SINGAPORE 212
- 9.4.7.1 Growing prevalence of diabetes to support market growth 212
9.4.8 REST OF ASIA PACIFIC 213
9.5 LATIN AMERICA 218
9.5.1 RECESSION IMPACT ON LATIN AMERICAN WOUND CARE MARKET 224
9.5.2 BRAZIL 224
- 9.5.2.1 Largest healthcare market in Latin America 224
9.5.3 MEXICO 225
- 9.5.3.1 Increasing burden of diabetes to propel market 225
9.5.4 REST OF LATIN AMERICA 226
9.6 MIDDLE EAST & AFRICA 231
9.6.1 RISING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH 231
9.6.2 RECESSION IMPACT ON MIDDLE EAST & AFRICAN WOUND CARE MARKET 236
10 COMPETITIVE LANDSCAPE 237
10.1 OVERVIEW 237
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 237
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN WOUND CARE MARKET 238
10.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS 240
10.4 MARKET SHARE ANALYSIS 241
10.4.1 WOUND CARE MARKET 241
10.4.2 ADVANCED WOUND CARE MARKET 242
10.4.3 NEGATIVE PRESSURE WOUND THERAPY (NPWT) MARKET 243
10.4.4 ADVANCED WOUND DRESSINGS MARKET 243
10.4.5 SURGICAL SUTURES MARKET 244
10.4.6 DEBRIDEMENT DEVICES MARKET 244
10.4.7 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET 245
10.5 COMPANY EVALUATION MATRIX 245
10.5.1 LIST OF EVALUATED VENDORS 245
10.5.2 STARS 245
10.5.3 EMERGING LEADERS 245
10.5.4 PERVASIVE PLAYERS 245
10.5.5 PARTICIPANTS 246
10.5.6 COMPANY FOOTPRINT 247
10.6 STARTUP/SME EVALUATION MATRIX 248
10.6.1 PROGRESSIVE COMPANIES 248
10.6.2 RESPONSIVE COMPANIES 248
10.6.3 DYNAMIC COMPANIES 248
10.6.4 STARTING BLOCKS 248
10.6.5 COMPETITIVE BENCHMARKING 250
10.7 COMPETITIVE SCENARIO 251
10.7.1 PRODUCT LAUNCHES 251
10.7.2 DEALS 252
11 COMPANY PROFILES 253
11.1 KEY PLAYERS 253
11.1.1 3M COMPANY 253
11.1.2 CARDINAL HEALTH 260
11.1.3 MEDTRONIC PLC 266
11.1.4 SMITH & NEPHEW PLC 271
11.1.5 MÖLNLYCKE HEALTH CARE AB 278
11.1.6 B. BRAUN MELSUNGEN AG 282
11.1.7 BAXTER INTERNATIONAL, INC 285
11.1.8 CONVATEC GROUP PLC 288
11.1.9 PAUL HARTMANN AG 292
11.1.10 COLOPLAST A/S 296
11.1.11 ORGANOGENESIS INC 299
11.1.12 MIMEDX GROUP, INC 302
11.1.13 INTEGRA LIFESCIENCES CORPORATION 305
11.1.14 BIOVENTUS LLC 309
11.1.15 ZIMMER BIOMET HOLDINGS, INC 312
11.2 OTHER PLAYERS 315
11.2.1 ETHICON, INC 315
11.2.2 DEROYAL INDUSTRIES, INC 316
11.2.3 KERECIS 318
11.2.4 ACELL INC 319
11.2.5 LOHMANN & RAUSCHER GMBH & CO. KG 320
11.2.6 MEDELA AG 322
11.2.7 TALLEY GROUP LTD 322
11.2.8 WELCARE INDUSTRIES S.P.A 323
11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD 323
11.2.10 PENSAR MEDICAL, LLC 324
11.2.11 HAROMED BV 325
11.2.12 DERMARITE INDUSTRIES, LLC 326
11.2.13 MEDLINE INDUSTRIES, INC 327
11.2.14 ADVANCIS MEDICAL LLC 330
11.2.15 MIL LABORATORIES PVT. LTD 331
12 APPENDIX 332
12.1 DISCUSSION GUIDE 332
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 337
12.3 CUSTOMIZATION OPTIONS 339
12.4 RELATED REPORTS 339
12.5 AUTHOR DETAILS 340
TABLE 1 TOTAL HEALTH EXPENDITURE DUE TO DIABETES (20-79 YEARS), BY COUNTRY, 2021 TABLE 2 PREVALENCE OF ROAD ACCIDENTS TABLE 3 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS TABLE 4 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS TABLE 5 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC REGION TABLE 6 AVERAGE SELLING PRICE OF KEY PRODUCTS IN WOUND CARE MARKET (2022) TABLE 7 AVERAGE SELLING PRICE TRENDS, BY REGION, 2022 TABLE 8 WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 13 IMPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018-2022 (USD MILLION) TABLE 14 EXPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018-2022 (USD MILLION) TABLE 15 WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS (%) TABLE 17 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS TABLE 18 WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 19 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 20 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 21 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 22 ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 23 KEY PRODUCTS IN FOAM DRESSINGS MARKET TABLE 24 FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 25 FOAM DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 26 SILICONE DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 27 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 28 KEY PRODUCTS IN HYDROCOLLOID DRESSINGS MARKET TABLE 29 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 30 FILM DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 31 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 32 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 33 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 34 HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 35 WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 36 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 37 OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 38 ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 39 NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 40 ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 41 WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 42 WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 43 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 44 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 45 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 46 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 47 KEY PRODUCTS IN BIOLOGICAL SKIN SUBSTITUTES MARKET TABLE 48 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 49 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 50 KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET TABLE 51 HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 52 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET TABLE 53 ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 54 BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 55 TOPICAL AGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 56 SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 57 SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 58 SUTURES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 59 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 60 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 61 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 62 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 63 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 64 STAPLERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 65 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 66 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 67 MEDICAL TAPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 68 DRESSINGS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 69 TYPES OF CLEANSING AGENTS TABLE 70 CLEANSING AGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 71 WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 72 WOUND CARE MARKET FOR ACUTE WOUNDS, BY TYPE, 2021-2028 (USD MILLION) TABLE 73 WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 74 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 75 WOUND CARE MARKET FOR BURNS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 76 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY TYPE, 2021-2028 (USD MILLION) TABLE 77 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 78 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE (20-79 AGE GROUP), 2021 TABLE 79 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 80 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 81 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 82 COMMERCIALLY AVAILABLE WOUND CARE BIOLOGIC PRODUCTS FOR OTHER CHRONIC WOUNDS TABLE 83 WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 84 WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 85 TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2021 TABLE 86 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2021-2028 (USD MILLION) TABLE 87 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 88 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 89 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 90 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 91 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 92 WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 93 WOUND CARE MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 94 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 95 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 96 NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 97 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 98 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 99 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 100 NORTH AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 101 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 102 NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 103 NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 104 NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 105 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 106 NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 107 US: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 108 US: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 109 CANADA: INCIDENCE OF DIABETES, 2022 VS. 2032 TABLE 110 CANADA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 111 CANADA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 112 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP), 2022 TABLE 113 EUROPE: PREVALENCE OF DIABETES, 2021 VS. 2045 TABLE 114 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 115 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 116 EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 117 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 118 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 119 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 120 EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 121 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 122 EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 123 EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 124 EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 125 EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 126 EUROPE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 127 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 128 GERMANY: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 129 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 130 FRANCE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 131 UK: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 132 UK: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 133 ITALY: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 134 ITALY: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 135 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 136 SPAIN: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 137 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 138 RUSSIA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 139 REST OF EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 140 REST OF EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 141 REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 142 REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 143 REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 144 REST OF EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 145 REST OF EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 146 REST OF EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 147 REST OF EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 148 REST OF EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 149 REST OF EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 150 REST OF EUROPE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 151 ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 152 ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 153 ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 154 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 155 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 156 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 157 ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 158 ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 159 ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 160 ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 161 ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 162 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 163 ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 164 CHINA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 165 CHINA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 166 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 167 JAPAN: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 168 INDIA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 169 INDIA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 170 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 171 AUSTRALIA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 172 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 173 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 174 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 175 SINGAPORE: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 176 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 177 REST OF ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 178 REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 179 REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 180 REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 181 REST OF ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 182 REST OF ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 183 REST OF ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 184 REST OF ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 185 REST OF ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 186 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 187 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 188 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 189 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 190 LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 191 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 192 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 193 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 194 LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 195 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 196 LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 197 LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 198 LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 199 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 200 LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 201 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 202 BRAZIL: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 203 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 204 MEXICO: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 205 REST OF LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 206 REST OF LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 207 REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 208 REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 209 REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 210 REST OF LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 211 REST OF LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 212 REST OF LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 213 REST OF LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 214 REST OF LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 215 REST OF LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 216 REST OF LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 217 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 218 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 219 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 220 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 221 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021-2028 (USD MILLION) TABLE 222 MIDDLE EAST & AFRICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 223 MIDDLE EAST & AFRICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 224 MIDDLE EAST & AFRICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 225 MIDDLE EAST & AFRICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 226 MIDDLE EAST & AFRICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 227 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE, 2021-2028 (USD MILLION) TABLE 228 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 229 OVERVIEW OF STRATEGIES ADOPTED BY KEY WOUND CARE COMPANIES TABLE 230 WOUND CARE MARKET: DEGREE OF COMPETITION TABLE 231 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2022 TABLE 232 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET TABLE 233 REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET TABLE 234 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS TABLE 235 WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES TABLE 236 KEY PRODUCT LAUNCHES TABLE 237 KEY DEALS TABLE 238 3M COMPANY: COMPANY OVERVIEW TABLE 239 CARDINAL HEALTH: COMPANY OVERVIEW TABLE 240 MEDTRONIC PLC: COMPANY OVERVIEW TABLE 241 SMITH & NEPHEW PLC: COMPANY OVERVIEW TABLE 242 MÖLNLYCKE HEALTH CARE AB: COMPANY OVERVIEW TABLE 243 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW TABLE 244 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW TABLE 245 CONVATEC GROUP PLC: COMPANY OVERVIEW TABLE 246 PAUL HARTMANN AG: COMPANY OVERVIEW TABLE 247 COLOPLAST A/S: COMPANY OVERVIEW TABLE 248 ORGANOGENESIS INC.: COMPANY OVERVIEW TABLE 249 MIMEDX GROUP, INC.: COMPANY OVERVIEW TABLE 250 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW TABLE 251 BIOVENTUS LLC: COMPANY OVERVIEW TABLE 252 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW TABLE 253 ETHICON, INC.: COMPANY OVERVIEW TABLE 254 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW TABLE 255 KERECIS: COMPANY OVERVIEW TABLE 256 ACELL INC.: COMPANY OVERVIEW TABLE 257 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW TABLE 258 MEDELA AG: COMPANY OVERVIEW TABLE 259 TALLEY GROUP LTD.: COMPANY OVERVIEW TABLE 260 WELCARE INDUSTRIES S.P.A: COMPANY OVERVIEW TABLE 261 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.: COMPANY OVERVIEW TABLE 262 PENSAR MEDICAL, LLC: COMPANY OVERVIEW TABLE 263 HAROMED BV: COMPANY OVERVIEW TABLE 264 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW TABLE 265 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW TABLE 266 ADVANCIS MEDICAL LLC: COMPANY OVERVIEW TABLE 267 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW
FIGURE 1 WOUND CARE MARKET: RESEARCH DESIGN FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS FIGURE 6 WOUND CARE MARKET: TOP-DOWN APPROACH FIGURE 7 DATA TRIANGULATION METHODOLOGY FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) FIGURE 9 WOUND CARE MARKET, BY WOUND TYPE, 2023 VS. 2028 (USD MILLION) FIGURE 10 WOUND CARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) FIGURE 11 WOUND CARE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) FIGURE 12 GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE MARKET FIGURE 13 ADVANCED WOUND CARE PRODUCTS SEGMENT TO DOMINATE MARKET IN 2028 FIGURE 14 CHRONIC WOUNDS SEGMENT DOMINATES MARKET DURING FORECAST PERIOD FIGURE 15 HOSPITALS & CLINICS WILL CONTINUE TO DOMINATE MARKET IN 2028 FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD FIGURE 17 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 18 PREVALENCE OF DIABETES IN ADULTS (20-79 YEARS), BY REGION, 2021 VS. 2045 (MILLION CASES) FIGURE 19 PATENT ANALYSIS OF WOUND CARE MARKET, JANUARY 2013-DECEMBER 2022 FIGURE 20 VALUE CHAIN ANALYSIS OF WOUND CARE MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES FIGURE 21 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS FIGURE 22 WOUND CARE MARKET: ECOSYSTEM ANALYSIS FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS FIGURE 24 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS FIGURE 25 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT FIGURE 26 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT FIGURE 27 REVENUE ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET, 2018-2022 (USD MILLION) FIGURE 28 WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 FIGURE 29 ADVANCED WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 FIGURE 30 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 FIGURE 31 ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 FIGURE 32 SURGICAL SUTURES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 FIGURE 33 DEBRIDEMENT DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 FIGURE 34 WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 FIGURE 35 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET FIGURE 36 WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022 FIGURE 37 3M COMPANY: COMPANY SNAPSHOT (2022) FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2022) FIGURE 39 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) FIGURE 40 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2022) FIGURE 41 MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2022) FIGURE 42 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) FIGURE 43 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022) FIGURE 44 CONVATEC GROUP: COMPANY SNAPSHOT (2022) FIGURE 45 PAUL HARTMANN AG: COMPANY SNAPSHOT (2022) FIGURE 46 COLOPLAST A/S: COMPANY SNAPSHOT (2022) FIGURE 47 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2022) FIGURE 48 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2022) FIGURE 49 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 50 BIOVENTUS LLC: COMPANY SNAPSHOT (2022) FIGURE 51 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022)
